QT interval feature (observable entity)
|
phenotype |
|
Clinical Attribute
|
75
|
226
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.070 |
None |
0.857 |
7 |
|
1996 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
0.750 |
4 |
|
2012 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.040 |
None |
0.750 |
4 |
|
2012 |
2020 |
Myelodysplasia
|
disease |
|
Congenital Abnormality
|
181
|
4
|
0.030 |
None |
1.000 |
3 |
|
1993 |
1994 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.030 |
None |
1.000 |
3 |
|
1993 |
1994 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2014 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3926
|
712
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2017 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
644
|
23
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant neoplasm of thymus
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
Therapy-related myelodysplastic syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
1993 |
1993 |
MSI-high
|
disease |
|
Neoplastic Process
|
83
|
9
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Thymus Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
31
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Thymic Lymphoma
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
45
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1597
|
326
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant neoplasm of endometrium
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1235
|
197
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |